C5AR2 and lung cancer: In breast and lung cancer, a survival niche for CSCs is provided through IL-6 and IL-8 secretion by CD10+/GPR77+ fibroblasts, a functionally distinct subset enriched in biopsies of chemoresistant tumors prior to chemotherapy [11].